KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

作者：Brad H. Rovin, Sharon G. Adler, Jonathan Barratt, Frank Bridoux, Kelly A. Burdge, Tak Mao Chan, H. Terence Cook, Fernando Custodio Fervenza, Keisha L. Gibson, Richard J. Glassock, David R.W. Jayne, Vivekanand Jha, Adrian Liew, Zhi-Hong Liu, Juan Manuel Mejia-Vilet, Carla Nester, Jai Radhakrishnan, Elizabeth M. Rave, Heather N. Reich, Pierre Marie Ronco, Jan‐Stephan Sanders, Sanjeev M. Sethi, Yusuke Suzuki, Sydney C.W. Tang, Vladimı́r Tesař, Marina Vivarelli, Jack F.M. Wetzels, Jürgen Floege · 发表于：Kidney International · 年份：2021 · DOI：10.1016/j.kint.2021.05.021 · 被引用次数：2537 · 研究领域：Renal Diseases and Glomerulopathies、Complement system in diseases、Platelet Disorders and Treatments

This guideline is published as a supplement supported by KDIGO. The development and publication of this guideline are strictly funded by KDIGO, and neither KDIGO nor its guideline Work Group members sought or received monies or fees from corporate or commercial entities in connection with this work. The opinions or views expressed in this professional education supplement are those of the authors and do not necessarily reflect the opinions or recommendations of the International Society of Nephrology or Elsevier. Dosages, indications, and methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the professional literature or other clinical sources. Because of the differences between in vitro and in vivo systems and between laboratory animal models and clinical data in humans, in vitro and animal data may not necessarily correlate with clinical results.